Get the latest tech news
Experimental drug looks to be gastric bypass surgery in pill form
Daily drug creates temporary coating in small intestine.
Today, the company announced early data from animals and a small group of human volunteers showing that its approach is safe and may be able to suppress hunger. “When nutrients are redirected to later in the intestine, you're activating pathways that lead towards satiety, energy expenditure, and overall healthy, sustainable weight loss,” Dhanda says. Vladimir Kushnir, professor of medicine and director of bariatric endoscopy at Washington University in St. Louis, who isn’t involved with Syntis, says the early pilot data is encouraging, but it’s hard to draw any conclusions from such a small study.
Or read this on r/technology